Evidence map›Paper›PMID 35035840›Full record

ArticleJournal of healthcare engineering2022

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile.

Hatim Z Almarzouki

Open access · hybridAbstract read
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Applications of artificial intelligence in urologic oncology.Investigative and clinical urology · 2024
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Hatim Z AlmarzoukiDepartment of Radiology, Faculty of Medicine, King Abdulaziz University Hospital, Jeddah, 21589, Saudi Arabia.ORCID 0000-0002-4178-1320
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quantity of data required to give a valid analysis grows exponentially as machine learning dimensionality increases. In a single experiment, microarrays or gene expression profiling assesses and determines gene expression levels and patterns in various cell types or tissues. The advent of DNA microarray technology has enabled simultaneous intensive care of hundreds of gene expressions on a single chip, advancing cancer categorization. The most challenging aspect of categorization is working out many information points from many sources. The proposed approach uses microarray data to train deep learning algorithms on extracted features and then uses the Latent Feature Selection Technique to reduce classification time and increase accuracy. The feature-selection-based techniques will pick the important genes before classifying microarray data for cancer prediction and diagnosis. These methods improve classification accuracy by removing duplicate and superfluous information. The Artificial Bee Colony (ABC) technique of feature selection was proposed in this research using bone marrow PC gene expression data. The ABC algorithm, based on swarm intelligence, has been proposed for gene identification. The ABC has been used here for feature selection that generates a subset of features and every feature produced by the spectators, making this a wrapper-based feature selection system. This method's main goal is to choose the fewest genes that are critical to PC performance while also increasing prediction accuracy. Convolutional Neural Networks were used to classify tumors without labelling them. Lung, kidney, and brain cancer datasets were used in the procedure's training and testing stages. Using the cross-validation technique of k-fold methodology, the Convolutional Neural Network has an accuracy rate of 96.43%. The suggested research includes techniques for preprocessing and modifying gene expression data to enhance future cancer detection accuracy.

Indexed as

Deep LearningNeoplasmsAlgorithmsGene ExpressionGene Expression ProfilingHumansOligonucleotide Array Sequence Analysis

Identifiers

PMID35035840
PMCPMC8759849
OpenAlexW4205415632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.